Overview of Lung Cancer and Key Updates in Therapy from ASCO

Explores the intricacies of lung cancer, providing listeners with a detailed overview, and discusses key therapeutic updates from ASCO 2024.

... Overview of Lung Cancer and Key Updates in Therapy from ASCO. No views · 1 minute ago RxConnect Podcast ...more. American Oncology Network. 345.

2024 ASCO Annual Meeting Recap – The Latest Research on Lung ...

This summary highlights key studies on NSCLC ... This innovative treatment has shown high efficacy in preclinical models of Small Cell Lung Cancer ...

ASCO 2024: Research Updates for the Lung Cancer Community

Palliative care delivery: in-person versus telehealth · Targeted therapy after chemoradiotherapy (CRT) for metastatic lung cancer · Immunotherapy ...

Podcast: ASCO24: Transforming the Lung Cancer Treatment ...

Drs. Vamsi Velcheti and Nathan Pennell discuss novel approaches and key studies in lung cancer that were showcased at the 2024 ASCO Annual ...

Data Updates in Lung Cancer at ASCO 2023 - Targeted Oncology

Data Updates in Lung Cancer at ASCO 2023 · 1: ADAURA: Overall Survival Analysis of Osimertinib in NSCLC · 2: KEYNOTE-789: Chemotherapy With or Without ...

Lung Cancer ASCO 2024 Practice Changing Highlights - YouTube

... ASCO 2024, focusing on key studies in lung cancer. Here's a quick summary of what you can expect in this episode: •⁠ ⁠LAURA Trial ...

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver ...

In 2022, ASCO launched living clinical practice guidelines for systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC) with and without ...

ASCO 2024 Updates: Novel Approaches in NSCLC Therapy - OncLive

The panel explores promising novel therapies in the treatment landscape, focusing on new or recently presented data at the American Society of Clinical ...

Lung Cancer - The ASCO Post

ASCO has issued a rapid update to its guideline on the management of stage III non–small cell lung cancer (NSCLC), based on the results of the phase III LAURA ...

Thoracic Cancer | ASCO - American Society of Clinical Oncology

Select a Guideline ; Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations Living Guideline. November 12, 2024 ; Therapy for Stage IV Non- ...

Non-small cell lung cancer: current treatment and future advances

Depending on the staging of lung cancer, patients are eligible for certain treatments ranging from surgery to radiation to chemotherapy as well as targeted ...

ASCO 2021 Lung cancer: Clinical insights into key research

Gilberto Lopes shares his lung cancer highlights from the 2021 ASCO Annual Meeting, including the IMpower010 trial, the MYLUNG study of real-world molecular ...

Key Data Updates From ASCO May Advance the Treatment ...

As the lung cancer paradigm continues to advance, increasingly effective therapies are under development for previously underserved disease ...

PowerPoint Presentation - American Society of Clinical Oncology

... Lung Cancer: ASCO Guideline. J Clin Oncol 40:1356-1384, 2022; Forde PM ... Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial. J ...

ASCO Releases Updated NSCLC Guidelines | Consultant360

... updated its 2015 guidelines on systemic therapy for stage IV non-small-cell lung cancer (NSCLC) ... description, patient history, image, and key hint?A. Kawasaki ...

Recent Advances in Lung Cancer: Summary of Presentations from ...

The use of molecularly targeted therapy has made a significant impact on the outcomes of patients with lung cancer. Further research is ongoing to identify more ...

Lung Cancer - ASCO Meeting Program Guide

Although pivotal trials stipulated ICI therapy for up to 2 years, many pts in clinical practice continue therapy beyond 2 years. Data on ...

Lung Cancer Guide | What You Need to Know

Read this short and simple guide about small cell lung cancer that covers diagnosis, treatment, questions to ask your doctor, and follow-up visits after ...

Why ASCO 2024 Was Being Called “ASCO Lung” - Patient Power

From the 2024 American Society of Clinical Oncologist (ASCO) annual meeting, Eric Kumar Singhi, MD, MD Anderson Cancer Center, joins Patient ...